233 Human PD-L2 triggers a unique T cell inhibitory program through PD-1 engagement distinct from that of PD-L1
Michael Curran,
Chao-Hsien Chen,
Qinying Liu,
Kimal Rajapakshe,
Cristian Coarfa,
Anupallavi Srinivasamani,
Shwetha Hegde
Affiliations
Michael Curran
Aff1 grid.240145.60000000122914776Department of ImmunologyUniversity of Texas MD Anderson Cancer Center Houston TX USA
Chao-Hsien Chen
Aff1 0000 0001 2291 4776grid.240145.6Department of ImmunologyUniversity of Texas MD Anderson Cancer Center U902 7455 Fannin St 77054 Houston TX USA
Qinying Liu
Aff7 0000 0001 2291 4776grid.240145.6Department of Investigational Cancer TherapeuticsThe University of Texas MD Anderson Cancer Center 1515 Holcombe Blvd., Unit 0455 77030 Houston TX USA
Kimal Rajapakshe
4 Ahmed Center for Pancreatic Cancer Research, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA
Cristian Coarfa
6 Department of Molecular and Cellular Biology, Baylor College of Medicine, Houston, Texas, USA
Anupallavi Srinivasamani
1University of Texas MD Anderson Cancer Center, Houston, TX, USA
Shwetha Hegde
1University of Texas MD Anderson Cancer Center, Houston, TX, USA